FDA seeks comments on new medical-imaging guidance

10/13/2008 | HealthImaging.com

The FDA is accepting public comments on a draft guidance for makers of medical-imaging drugs and devices that provide contrast enhancement. The guidance focuses on developing new contrast indications for imaging devices that use approved drugs or biological products. It also contains recommendations to promote the timely and effective evaluation and regulation of imaging drugs and devices.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA